Page last updated: 2024-11-07

n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine: fluorescent probe for membrane lipids [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123850
MeSH IDM0124478

Synonyms (7)

Synonym
2,3-dihydroxypropyl 2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]ethyl hydrogen phosphate
64205-19-2
n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine
n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-sn-glycero-3-phosphoethanolamine
phosphoric acid, mono(2,3-dihydroxypropyl)mono(2-((7-nitro-4-benzofurazanyl)amino)ethyl) ester
IIAMEYUVJZGTTM-UHFFFAOYSA-N
DTXSID40982750

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Drug candidates under development by industry frequently show phospholipidosis as a side-effect in pre-clinical toxicity studies."( Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
Horinouchi, A; Matsumoto, A; Miyamoto, S; Mori, I, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (110)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (18.18)18.7374
1990's49 (44.55)18.2507
2000's30 (27.27)29.6817
2010's11 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.82 (24.57)
Research Supply Index4.74 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other113 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]